Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues

Joshua A. Kulas, Whitney F. Franklin, Nicholas A. Smith, Gunjan D. Manocha, Kendra L. Puig, Kumi Nagamoto-Combs, Rachel D. Hendrix, Giulio Taglialatela, Steven W. Barger, Colin K. Combs

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The amyloid precursor protein (APP) is a type I transmembrane glycoprotein widely studied for its role as the source of β-amyloid peptide, accumulation of which is causal in at least some cases of Alzheimer's disease (AD). APP is expressed ubiquitously and is involved in diverse biological processes. Growing bodies of evidence indicate connections between AD and somatic metabolic disorders related to type 2 diabetes, and App-/- mice show alterations in glycemic regulation. We find that App-/- mice have higher levels of insulin-degrading enzyme (IDE) mRNA, protein, and activity compared with wild-type controls. This regulation of IDE by APP was widespread across numerous tissues, including liver, skeletal muscle, and brain as well as cell types within neural tissue, including neurons, astrocytes, and microglia. RNA interference-mediated knockdown of APP in the SIM-A9 microglia cell line elevated IDE levels. Fasting levels of blood insulin were lower in App-/- than App+/+ mice, but the former showed a larger increase in response to glucose. These low basal levels may enhance peripheral insulin sensitivity, as App-/- mice failed to develop impairment of glucose tolerance on a high-fat, high-sucrose ("Western") diet. Insulin levels and insulin signaling were also lower in the App-/- brain; synaptosomes prepared from App-/- hippocampus showed diminished insulin receptor phosphorylation compared with App+/+ mice when stimulated ex vivo. These findings represent a new molecular link connecting APP to metabolic homeostasis and demonstrate a novel role for APP as an upstream regulator of IDE in vivo.

Original languageEnglish (US)
Pages (from-to)E106-E120
JournalAmerican journal of physiology. Endocrinology and metabolism
Volume316
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Insulysin
Amyloid beta-Protein Precursor
Brain
Microglia
Insulin
Alzheimer Disease
Amyloidogenic Proteins
Biological Phenomena
Glucose
Enzyme Precursors
Synaptosomes
Insulin Receptor
RNA Interference
Amyloid
Astrocytes
Type 2 Diabetes Mellitus
Sucrose
Insulin Resistance
Fasting
Hippocampus

Keywords

  • Alzheimer’s disease
  • amyloid precursor protein
  • insulin
  • insulin-degrading enzyme
  • microglia

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Physiology (medical)

Cite this

Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. / Kulas, Joshua A.; Franklin, Whitney F.; Smith, Nicholas A.; Manocha, Gunjan D.; Puig, Kendra L.; Nagamoto-Combs, Kumi; Hendrix, Rachel D.; Taglialatela, Giulio; Barger, Steven W.; Combs, Colin K.

In: American journal of physiology. Endocrinology and metabolism, Vol. 316, No. 1, 01.01.2019, p. E106-E120.

Research output: Contribution to journalArticle

Kulas, Joshua A. ; Franklin, Whitney F. ; Smith, Nicholas A. ; Manocha, Gunjan D. ; Puig, Kendra L. ; Nagamoto-Combs, Kumi ; Hendrix, Rachel D. ; Taglialatela, Giulio ; Barger, Steven W. ; Combs, Colin K. / Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. In: American journal of physiology. Endocrinology and metabolism. 2019 ; Vol. 316, No. 1. pp. E106-E120.
@article{dc4decb43b1b410480f14e5c5e9aeaae,
title = "Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues",
abstract = "The amyloid precursor protein (APP) is a type I transmembrane glycoprotein widely studied for its role as the source of β-amyloid peptide, accumulation of which is causal in at least some cases of Alzheimer's disease (AD). APP is expressed ubiquitously and is involved in diverse biological processes. Growing bodies of evidence indicate connections between AD and somatic metabolic disorders related to type 2 diabetes, and App-/- mice show alterations in glycemic regulation. We find that App-/- mice have higher levels of insulin-degrading enzyme (IDE) mRNA, protein, and activity compared with wild-type controls. This regulation of IDE by APP was widespread across numerous tissues, including liver, skeletal muscle, and brain as well as cell types within neural tissue, including neurons, astrocytes, and microglia. RNA interference-mediated knockdown of APP in the SIM-A9 microglia cell line elevated IDE levels. Fasting levels of blood insulin were lower in App-/- than App+/+ mice, but the former showed a larger increase in response to glucose. These low basal levels may enhance peripheral insulin sensitivity, as App-/- mice failed to develop impairment of glucose tolerance on a high-fat, high-sucrose ({"}Western{"}) diet. Insulin levels and insulin signaling were also lower in the App-/- brain; synaptosomes prepared from App-/- hippocampus showed diminished insulin receptor phosphorylation compared with App+/+ mice when stimulated ex vivo. These findings represent a new molecular link connecting APP to metabolic homeostasis and demonstrate a novel role for APP as an upstream regulator of IDE in vivo.",
keywords = "Alzheimer’s disease, amyloid precursor protein, insulin, insulin-degrading enzyme, microglia",
author = "Kulas, {Joshua A.} and Franklin, {Whitney F.} and Smith, {Nicholas A.} and Manocha, {Gunjan D.} and Puig, {Kendra L.} and Kumi Nagamoto-Combs and Hendrix, {Rachel D.} and Giulio Taglialatela and Barger, {Steven W.} and Combs, {Colin K.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1152/ajpendo.00279.2018",
language = "English (US)",
volume = "316",
pages = "E106--E120",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues

AU - Kulas, Joshua A.

AU - Franklin, Whitney F.

AU - Smith, Nicholas A.

AU - Manocha, Gunjan D.

AU - Puig, Kendra L.

AU - Nagamoto-Combs, Kumi

AU - Hendrix, Rachel D.

AU - Taglialatela, Giulio

AU - Barger, Steven W.

AU - Combs, Colin K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The amyloid precursor protein (APP) is a type I transmembrane glycoprotein widely studied for its role as the source of β-amyloid peptide, accumulation of which is causal in at least some cases of Alzheimer's disease (AD). APP is expressed ubiquitously and is involved in diverse biological processes. Growing bodies of evidence indicate connections between AD and somatic metabolic disorders related to type 2 diabetes, and App-/- mice show alterations in glycemic regulation. We find that App-/- mice have higher levels of insulin-degrading enzyme (IDE) mRNA, protein, and activity compared with wild-type controls. This regulation of IDE by APP was widespread across numerous tissues, including liver, skeletal muscle, and brain as well as cell types within neural tissue, including neurons, astrocytes, and microglia. RNA interference-mediated knockdown of APP in the SIM-A9 microglia cell line elevated IDE levels. Fasting levels of blood insulin were lower in App-/- than App+/+ mice, but the former showed a larger increase in response to glucose. These low basal levels may enhance peripheral insulin sensitivity, as App-/- mice failed to develop impairment of glucose tolerance on a high-fat, high-sucrose ("Western") diet. Insulin levels and insulin signaling were also lower in the App-/- brain; synaptosomes prepared from App-/- hippocampus showed diminished insulin receptor phosphorylation compared with App+/+ mice when stimulated ex vivo. These findings represent a new molecular link connecting APP to metabolic homeostasis and demonstrate a novel role for APP as an upstream regulator of IDE in vivo.

AB - The amyloid precursor protein (APP) is a type I transmembrane glycoprotein widely studied for its role as the source of β-amyloid peptide, accumulation of which is causal in at least some cases of Alzheimer's disease (AD). APP is expressed ubiquitously and is involved in diverse biological processes. Growing bodies of evidence indicate connections between AD and somatic metabolic disorders related to type 2 diabetes, and App-/- mice show alterations in glycemic regulation. We find that App-/- mice have higher levels of insulin-degrading enzyme (IDE) mRNA, protein, and activity compared with wild-type controls. This regulation of IDE by APP was widespread across numerous tissues, including liver, skeletal muscle, and brain as well as cell types within neural tissue, including neurons, astrocytes, and microglia. RNA interference-mediated knockdown of APP in the SIM-A9 microglia cell line elevated IDE levels. Fasting levels of blood insulin were lower in App-/- than App+/+ mice, but the former showed a larger increase in response to glucose. These low basal levels may enhance peripheral insulin sensitivity, as App-/- mice failed to develop impairment of glucose tolerance on a high-fat, high-sucrose ("Western") diet. Insulin levels and insulin signaling were also lower in the App-/- brain; synaptosomes prepared from App-/- hippocampus showed diminished insulin receptor phosphorylation compared with App+/+ mice when stimulated ex vivo. These findings represent a new molecular link connecting APP to metabolic homeostasis and demonstrate a novel role for APP as an upstream regulator of IDE in vivo.

KW - Alzheimer’s disease

KW - amyloid precursor protein

KW - insulin

KW - insulin-degrading enzyme

KW - microglia

UR - http://www.scopus.com/inward/record.url?scp=85059497657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059497657&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00279.2018

DO - 10.1152/ajpendo.00279.2018

M3 - Article

C2 - 30422705

AN - SCOPUS:85059497657

VL - 316

SP - E106-E120

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 1

ER -